I agree that this site is using cookies. You can find further informations here.
X
Masterman, Donna L.
45  results:
Search for persons X
?
1

Interpretable discriminant analysis for functional data sup..:

Lila, Eardi ; Zhang, Wenbo ; Rane Levendovszky, Swati...
Journal of the Royal Statistical Society Series B: Statistical Methodology.  , 2024
Link: https://doi.org/10.1093/..
 
?
2

Plasma phosphorylated-tau181 as a predictive biomarker for ..:

Shen, Xue-Ning ; Huang, Yu-Yuan ; Chen, Shi-Dong...
Translational Psychiatry.  11 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
3

Higher CSF sTNFR1-related proteins associate with better pr..:

Hu, William T. ; Ozturk, Tugba ; Kollhoff, Alexander...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
4

Evaluation of shorter infusion times with ocrelizumab in pa..:

Vollmer, Timothy ; Alvarez, Enrique ; Nair, Kavita...
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
?
5

Confirmed Disability Progression in Different Subgroups of ..:

Turner, Benjamin ; Cree, Bruce ; Lorscheider, Johannes...
Neurology.  90 (2018)  15_supplement - p. , 2018
Link: https://doi.org/10.1212/..
 
?
6

Effects of Ocrelizumab on Neurofilament Light Chain and Oth..:

Herman, Ann ; Musch, Bruno ; Harp, Christopher...
Neurology.  88 (2017)  16_supplement - p. , 2017
Link: https://doi.org/10.1212/..
 
?
7

Evaluation of No Evidence of Progression or Active Disease ..:

Wolinsky, Jerry ; Montalban, Xavier ; Kappos, Ludwig...
Neurology.  88 (2017)  16_supplement - p. , 2017
Link: https://doi.org/10.1212/..
 
?
8

Effect of Ocrelizumab on MRI Inflammatory and Neurodegenera..:

Arnold, Douglas ; Bar-Or, Amit ; Comi, Giancarlo...
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
?
9

Effect of Ocrelizumab on Disability Progression in Patients..:

Comi, Giancarlo ; Arnold, Douglas ; Bar-Or, Amit...
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
?
10

Efficacy and Safety of Ocrelizumab in Primary Progressive M..:

Montalban, Xavier ; Hemmer, Bernhard ; Rammohan, Kottil...
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
?
11

Efficacy of Ocrelizumab in Patients with Relapsing Multiple..:

Hauser, Stephen ; Arnold, Douglas ; Bar-Or, Amit...
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
?
12

Ocrelizumab No Evidence of Disease Activity (NEDA) Status a..:

Traboulsee, Anthony ; Arnold, Douglas ; Bar-Or, Amit...
Neurology.  86 (2016)  16_supplement - p. , 2016
Link: https://doi.org/10.1212/..
 
?
13

Immunoglobulin M oligoclonal bands: Biomarker of targetable..:

Villar, Luisa M. ; Casanova, Bonaventura ; Ouamara, Nadia...
Annals of Neurology.  76 (2014)  2 - p. 231-240 , 2014
Link: https://doi.org/10.1002/..
 
?
14

Week 144 Results of a Phase II, Randomized, Multicenter Tri..:

Hauser, Stephen ; Li, David ; Calabresi, Peter...
Neurology.  80 (2013)  7_supplement - p. , 2013
Link: https://doi.org/10.1212/..
 
?
15

Oral curcumin for Alzheimer's disease: tolerability and eff..:

Ringman, John M ; Frautschy, Sally A ; Teng, Edmond...
Alzheimer's Research & Therapy.  4 (2012)  5 - p. 43 , 2012
Link: https://doi.org/10.1186/..
 
1-15